Thank you for your patience. Your civilization is very important to us.
Thank you for your patience. Your civilization is very important to us.
Condition
Clinical trials and treatment information for Invasive Non-typhoidal Salmonella (iNTS)
Ranked by evidence volume first. Medicine has spent centuries ranking things by vibes. This is an improvement.
Comparative Safety Scale(Higher is safer)
Time to Effect
1-2 days
Duration
7-14 days
Response Rate
95%
Remission Rate
95%
Common Side Effects:
Annual Cost of Care
Drug Cost
$2,000
Monitoring
$1,000
Side Effects
$100
Total Annual
$3,100
Cost-Effectiveness
GOODQALYs Gained
0.25
Cost per Remission
$3,263
Cost per Responder
$3,263
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
2-3 days
Duration
7-14 days
Response Rate
90%
Remission Rate
90%
Common Side Effects:
Annual Cost of Care
Drug Cost
$150
Monitoring
$500
Side Effects
$50
Total Annual
$700
Cost-Effectiveness
EXCELLENTQALYs Gained
0.2
Cost per Remission
$778
Cost per Responder
$778
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
1-2 days
Duration
7-14 days
Response Rate
85%
Remission Rate
85%
Common Side Effects:
Annual Cost of Care
Drug Cost
$50
Monitoring
$500
Side Effects
$50
Total Annual
$600
Cost-Effectiveness
EXCELLENTQALYs Gained
0.2
Cost per Remission
$706
Cost per Responder
$706
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
3-5 days
Duration
7-14 days
Response Rate
80%
Remission Rate
80%
Common Side Effects:
Annual Cost of Care
Drug Cost
$40
Monitoring
$500
Side Effects
$50
Total Annual
$590
Cost-Effectiveness
EXCELLENTQALYs Gained
0.18
Cost per Remission
$738
Cost per Responder
$738
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
3-5 days
Duration
7-14 days
Response Rate
75%
Remission Rate
75%
Common Side Effects:
Annual Cost of Care
Drug Cost
$30
Monitoring
$500
Side Effects
$50
Total Annual
$580
Cost-Effectiveness
EXCELLENTQALYs Gained
0.15
Cost per Remission
$773
Cost per Responder
$773
Clinical Trial Phases: